Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
Clinicopathological parameters | All(a) n(%) | No Relapse n(%) | Relapse n(%) | OR [CI 95%] | p | OR [CI 95%] | p |
G2I (b) | |||||||
Class 1 | 19 (14) | 18 (20) | 1 (2,2) | 0,16[0,2-1,2] | 0,08 | 0,24[0.03-2] | 0.19 |
Class2 | 88 (65) | 65 (72,2) | 23 (51,1) | 1 | 1 | ||
Class3 | 28 (21) | 7 (7,8) | 21 (46,7) | 8,5[3 ,2-22,6] | <0,001 | 11.9[4.2-34.1] | <0.001 |
SBR Grade (c) | rejected | ||||||
1 | 25 (18) | 21 (23,3) | 4 (8,9) | 1 | |||
2 | 71 (53) | 46 (51,1) | 25 (55,6) | 2,9[0,9-9,2] | 0,08 | ||
3 | 39 (29) | 23 (25,6) | 16 (35,6) | 3,7[1,05-12,7] | 0,04 | ||
Histological size | rejected | ||||||
≤ 20 mm. | 90 (67) | 67 (74,4) | 23 (51,1) | 1 | |||
> 20 mm. | 45 (33) | 23 (25,6) | 22 (48,9) | 2,8[1, 3–5, 9] | 0,008 | ||
HR status (d) | |||||||
HR- | 19 (14) | 12 (13,3) | 7 (15,6) | 1,19[0 ,44- | 0,72 | ||
HR+ | 116 (86) | 78 (86,7) | 38 (84,4) | 3,3] | |||
NPI (e) | |||||||
1 + 2 | 30 (22) | 24 (26,7) | 6 (13,3) | 1 | 1 | ||
3 | 85 (63) | 58 (64,4) | 27 (60) | 1,8[0,7-5,1] | 0,23 | 1.38[0.4-4.4] | 0.6 |
4 | 20 (15) | 8 (8,9) | 12 (26,7) | 6[1,7-21,3] | 0,006 | 7.2[1.8-29.3 | 0.006 |
TP53 alteration | |||||||
no | 115 (85) | 73 (81,1) | 31 (68,9) | 1 | |||
yes | 20 (15) | 17 (18,9) | 14 (31,1) | 1,9[0,9-4,4] | 0,11 | ||
mib1 (f) | rejected | ||||||
<20% | 93 (69) | 67 (74,4) | 26 (57,8) | 1 | |||
≥20% | 42 (31) | 23 (25,6) | 19 (42,2) | 2,1[1–4,5] | 0,05 | ||
IHC intrinsic class (g) | |||||||
LA | 83 (62) | 59 (67) | 24 (53,3) | 1 | |||
LB + Her2+ Basal | 50 (38) | 29 (33) | 21 (37,6) | 1,8[0,85-3,7] | 0,12 | ||
nd | 2 | 2 |